NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE79059 Query DataSets for GSE79059
Status Public on Mar 07, 2019
Title Cyclophilin D-dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary We aimed to understand the role of cyclophilin D (CypD)-dependent mitochondrial permeability transition (mPT) in the immunosuppressive phase of lipopolysaccharide (LPS)-induced endotoxic shock. The liver plays an important role in immunity and organ dysfunction; therefore, on liver RNA sequencing (RNAseq) data, Ingenuity® Pathway Analysis (IPA ®) was used to investigate the complex role of mPT formation in inflammatory reprogramming and disease progression. LPS induced significant changes in the expression of 2715 genes, affecting 179 pathways related to mitochondrial dysfunction, defective oxidative phosphorylation, nitric oxide (NO) and reactive oxygen species (ROS) accumulation, nuclear factor, erythroid 2 like 2 (Nrf2), Toll-like receptors (TLRs), and tumor necrosis factor α receptors (TNFRs) mediated processes in wild-type mice. The disruption of CypD reduced the LPS-induced alterations in gene expression and pathways involving TNFRs and TLRs, in addition to improving survival and attenuating oxidative liver damage and the related NO- and ROS-producing pathways. CypD deficiency diminished the suppressive effect of LPS on mitochondrial function, nuclear- and mitochondrial-encoded genes, and mitochondrial DNA (mtDNA) quantity, which could be critical in improving survival. Our data propose that CypD-dependent mPT is an amplifier in inflammatory reprogramming and promotes disease progression. The mortality in human sepsis and shock is associated with mitochondrial dysfunction. Prevention of mPT by CypD disruption reduces inflammatory reprogramming, mitochondrial dysfunction, and lethality; therefore, CypD can be a novel drug target in endotoxic shock and related inflammatory diseases.
 
Overall design Comparison of CypD-/- and wild type mice in an endotoxemia model
 
Contributor(s) Veres B, Eros K, Antus C, Kalman N, Fonai F, Jakus PB, Boros E, Hegedus Z, Nagy I, Tretter L, Gallyas F Jr, Sumegi B
Citation(s) 33471430
Submission date Mar 10, 2016
Last update date Mar 23, 2021
Contact name Balazs Horvath
Organization name SeqOmics Biotechnology Ltd.
Department NGSP
Street address Vallalkozok u. 7.
City Morahalom
ZIP/Postal code 6782
Country Hungary
 
Platforms (1)
GPL15907 AB 5500xl Genetic Analyzer (Mus musculus)
Samples (4)
GSM2084745 CyD_neg_CTRL
GSM2084746 CyD_plus_CTRL
GSM2084747 CyD_neg_LPS
Relations
BioProject PRJNA314843
SRA SRP071567

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE79059_CypD_KO_LPS_vs_CypD_KO_Cl.xls.gz 49.5 Kb (ftp)(http) XLS
GSE79059_CypD_KO_LPS_vs_WT_LPS_Cl.xls.gz 35.3 Kb (ftp)(http) XLS
GSE79059_CypD_KO_vs_WT_Cl.xls.gz 14.9 Kb (ftp)(http) XLS
GSE79059_WT_LPS_vs_WT_Cl.xls.gz 89.8 Kb (ftp)(http) XLS
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap